Stephen Shorofsky is a Cardiac Electrophysiologist and a Cardiologist in Baltimore, Maryland. Dr. Shorofsky is rated as a Distinguished provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Arrhythmias, Ventricular Tachycardia, Paroxysmal Supraventricular Tachycardia (PSVT), Cardiac Ablation, and Pacemaker Implantation. Dr. Shorofsky is currently accepting new patients.

Timm-michael Dickfeld is a Cardiologist and a Cardiac Electrophysiologist in Baltimore, Maryland. Dr. Dickfeld is rated as a Distinguished provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Catecholaminergic Polymorphic Ventricular Tachycardia, Ventricular Tachycardia, His Bundle Tachycardia, Cardiac Ablation, and Pacemaker Implantation. Dr. Dickfeld is currently accepting new patients.

Vikas Kalra is a Cardiac Electrophysiologist and a Cardiologist in Towson, Maryland. Dr. Kalra is rated as an Advanced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Atrial Fibrillation, Bidirectional Tachycardia, Catecholaminergic Polymorphic Ventricular Tachycardia, Pacemaker Implantation, and Cardiac Ablation. Dr. Kalra is currently accepting new patients.

Joseph Marine, MD, MBA, FACC, FHRS, is a clinical cardiac electrophysiologist who practices primarily at the Johns Hopkins Hospital in Baltimore, Maryland. He is a Professor of Medicine at the Johns Hopkins University School of Medicine and holds appointments as Vice-Director of Operations for the Division of Cardiology and Section Chief of Cardiology for Johns Hopkins Community Physicians. He trained at UC San Francisco Medical School, Brigham and Women’s Hospital/Harvard Medical School, Boston University Medical Center, and Beth Israel Deaconess Medical Center. Dr. Marine has lectured widely on a variety of arrhythmia topics and has served as a co-director of the American College of Cardiology (ACC) Cardiovascular Overview and Board Review Course for 10 years. He currently serves on the ACC Board of Governors and is co-editor of the ACC/HRS EP Self-Assessment Program. He also serves on other committees for the ACC, the Heart Rhythm Society, and MedChi. He is co-author of more than 130 original research and review articles and has served on writing committees for several national cardiology practice and training guidelines. As a clinical cardiac electrophysiologist, Dr. Marine specializes in the diagnosis and treatment of arrhythmias, which are heart rhythm disorders that cause the heart to beat too rapidly, too slowly, or irregularly. His research focuses on further improving the safety and effectiveness of catheter ablation and other treatments for atrial fibrillation and other atrial and ventricular arrhythmias. Dr. Marine is rated as an Advanced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Atrial Fibrillation, Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Arrhythmias, Cardiac Ablation, and Heart Transplant.

Ilan Wittstein is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist in Baltimore, Maryland. Dr. Wittstein is rated as an Advanced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Cardiomyopathy, Arrhythmias, Familial Ventricular Tachycardia, Cardiac Ablation, and Heart Transplant. Dr. Wittstein is currently accepting new patients.

Dr. Hugh Calkins is the Catherine Ellen Poindexter Professor of Cardiology and Director of the Electrophysiology Laboratory and Arrhythmia Service at the Johns Hopkins Hospital. He is an internationally recognized expert on catheter ablation, atrial fibrillation, syncope, arrhythmogenic right ventricular dysplasia (ARVD) and arrhythmia management. Dr. Calkins attended Williams College and Harvard Medical School before training in medicine at Massachusetts General Hospital. He received his cardiology training at Johns Hopkins. His first faculty position was at the University of Michigan, where he directed the Pacemaker Service, and he returned to Johns Hopkins as director of the Arrhythmia Service in 1992. Dr. Calkins is an Associate Editor of the Journal of Cardiovascular Electrophysiology and is on the editorial board of many other cardiology journals. He is a former member of the American Board of Internal Medicine Electrophysiology Boards Test Writing Committee. Dr. Calkins is a fellow of the American College of Cardiology, the American Heart Association and the Heart Rhythm Society. He led a 44-member international task force whose 2012 Expert Consensus Statement gave recommendations for treatment and research of atrial fibrillation. Dr Calkins is a past president of the Heart Rhythm Society and was elected to be a member of the Miler Coulsen Academy of Clinical Excellence in 2014. Dr. Calkins has published more than 500 articles and book chapters on a large variety of cardiac arrhythmias. His research has focused predominantly on catheter ablation, atrial fibrillation, syncope, and arrhythmogenic right ventricular dysplasia. Dr. Calkins has also written extensively on most aspects of heart rhythm disorders and their treatment. Dr. Calkins is rated as an Experienced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Atrial Fibrillation, Arrhythmias, Cardiomyopathy, Cardiac Ablation, and Heart Transplant.

Edward K. Kasper, M.D. is a graduate of the Johns Hopkins University with a B.A. in Natural Sciences. He earned his M.D. at the University of Connecticut School of Medicine in 1984. His internship and residency in Internal Medicine, as well as his fellowship in Cardiovascular Medicine, were completed at the Johns Hopkins Hospital, where he then joined the faculty in 1993. He is a fellow of the American Heart Association as well as a fellow of the American College of Cardiology, having served on its board of governors from 2002 to 2006. Dr. Kasper has authored more than 100 articles and three books including, Living Well with Heart Failure. He is currently the Director of Outpatient Cardiology. Dr. Kasper's current research interests focus on the biological origins of heart failure. Specifically, his research has focused on causes and prognosis of patients with cardiomyopathy, a serious condition in which the heart has difficulty pumping blood throughout the body. Dr. Kasper works closely with his team at the Johns Hopkins Heart and Vascular Institute to understand the best ways to predict and prevent catastrophic cardiac events. With your support, Dr. Kasper will be able to continue his significant work in cardiovascular medicine in hopes of impacting the future of patients with cardiomyopathy and heart failure. Dr. Kasper is rated as an Experienced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Cardiomyopathy, Familial Hypertrophic Cardiomyopathy, Sengers Syndrome, Hypertrophic Cardiomyopathy (HCM), and Heart Transplant.

Degrees: BS: Massachusetts Institute of Technology 1981 Electrical Engineering MS: Massachusetts Institute of Technology 1983 Electrical Engineering PhD: Massachusetts Institute of Technology 1987 Electrical Engineering MD: Harvard 1987 Medicine Professional Appointments: 1987-1988 Intern in Medicine, Brigham and Women's Hospital 1988-1990 Resident in Medicine, Brigham and Women's Hospital 1988-1990 Research Scientist, Harvard M.I.T. Division of H.S.T. 1990-1993 Fellow in Cardiology, Johns Hopkins University 1993-1998 Assistant Professor of Medicine, Johns Hopkins University 1996- Co-Director of Cardiac Electrophysiology, Johns Hopkins Hospital 1998-2005 Associate Professor of Medicine, Johns Hopkins University 2002-2005 Associate Professor of Biomedical Engineering, Johns Hopkins University 2005- Professor of Medicine, Johns Hopkins University 2005- Professor of Biomedical Engineering, Johns Hopkins University. Dr. Berger is rated as an Experienced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Atrial Fibrillation, Arrhythmias, Ventricular Tachycardia, Cardiac Ablation, and Pacemaker Implantation.

Charles Love is director of the Johns Hopkins Cardiac Rhythm Device Service. Dr. Love is one of the foremost international authorities on pacemaker and implantable cardioverter defibrillator implantation and management. He manages patients with all types of heart rhythm disorders and has particular interest in lead extraction and lead management strategies, with an emphasis on new tools to reduce complications and strategies to reduce infection. Dr. Love is rated as an Experienced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Arrhythmias, Sick Sinus Syndrome, Ventricular Tachycardia, Pacemaker Implantation, and Cardiac Ablation.

Dr. Brian Gustav Kral is Assistant Professor in the Division of Cardiology and General Internal Medicine as well as Assistant Professor of Radiology and Radiological Sciences at the Johns Hopkins School of Medicine. He is currently engaged in research on genetic and biological mechanisms of coronary atherosclerosis with an emphasis on plaque morphology and composition as well as coronary blood flow at different stages of disease progression. Dr. Kral received his undergraduate degree in economics and pre-medicine from The Johns Hopkins University. He received a master’s in public health from The Johns Hopkins School of Public Health. He also earned a medical degree from The Johns Hopkins School of Medicine. Dr. Kral completed his residency at the Mayo Graduate School of Medicine. He rejoined the Johns Hopkins community as a fellow in 2005 where he remained on Faculty after completion of his training. Besides his teaching and clinical engagements, Dr. Kral is currently the Program Director of Nuclear Cardiology at the Johns Hopkins School of Medicine. Dr. Kral is also Director of Clinical Studies for The Johns Hopkins GeneSTAR Research Program. The program aims to identify genetic and biological determinants of subclinical and clinical atherosclerotic disease and thrombosis in individuals with a strong family history of early-onset coronary artery disease. He has been recognized with the Stanley L. Blumenthal Cardiology Research Award for outstanding clinical research in cardiovascular disease from The Johns Hopkins Medical Institutions. Dr. Kral is rated as an Experienced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Apoplexy, Coronary Heart Disease, Heart Attack, Pacemaker Implantation, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Chiadi Ndumele is the Director of Obesity and Cardiometabolic Research, Director of the Heart Failure Prevention Program and Associate Professor of Medicine and Epidemiology in the Division of Cardiology at Johns Hopkins University. Dr. Ndumele is a preventive cardiologist with doctorate level training in epidemiology, who leads a research program related to characterizing the relationship of obesity and cardiometabolic risk factors with the development of cardiovascular disease, with a particular focus on heart failure risk, and to refining strategies for cardiovascular disease prevention. His work additionally addresses the impact of social determinants of health on cardiometabolic risk factors and downstream cardiovascular outcomes. Dr. Ndumele received his M.D. from Harvard University and his Internal Medicine training at Brigham and Women’s Hospital, where he also served as Chief Medical Resident. He subsequently trained in Cardiology at Johns Hopkins University, where he was also Chief Cardiology Fellow in his final year and where he also received his MHS and PhD in Epidemiology. Dr. Ndumele’s research has been supported by multiple grants from the NIH, Robert Wood Johnson Foundation and the American Heart Association (AHA). He is Chair of the Council on Lifestyle and Cardiometabolic Health of the AHA, Past Chair of the AHA Obesity Committee, and Co-Chair of the AHA Cardiovascular-Kidney-Metabolic Health Initiative. Dr. Ndumele is rated as an Experienced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Atherosclerosis, Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), and Metabolic Syndrome.

Dr. Cingolani is an Associate Professor at The Johns Hopkins University School of Medicine, Division of Cardiology. He earned his medical degree from Universidad Nacional de La Plata, Argentina, and completed his Internship and Internal Medicine Residency at CEMIC, Buenos Aires, Argentina, and hypertension research post-doctoral fellowship at Henry Ford Hospital, Detroit, MI. After completing his Internal Medicine Residency at The Reading Hospital and Medical Center in Pennsylvania, Dr. Cingolani joined The Johns Hopkins Hospital as a Cardiology fellow, where he remained in the Faculty after his training. Currently, he is the Associate Director of The Johns Hopkins Hospital Coronary Care Unit, Director of the Hypertension Center and member of the Echocardiography Lab and Outpatient Cardiology Clinic. He also teaches pathophysiology to medical students. Dr. Cingolani’s research interests focus on hypertensive heart disease and its transition to heart failure. He aims to elucidate the mechanism/s by which certain matricellular proteins present in the heart seem to play a protective role. His research is mainly supported by the National Institute of Health (NIH). He is also the principal investigator of the DREAM study group, studying the effect of Melatonin in preventing atrial fibrillation in patients undergoing cardiac surgery. Dr. Cingolani has been recognized by the Council for High Blood Pressure Research of the American Heart Association for his work in hypertension and is the 2011 recipient of the PJ Schafer Memorial Heart Research Award, the 2012 Michel Mirowski Discovery Fund Award, and 2013 Magic that matters Fund. Dr. Cingolani is rated as an Experienced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Paroxysmal Supraventricular Tachycardia (PSVT), Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Multifocal Atrial Tachycardia, Cardiac Ablation, and Tissue Biopsy.

Kavita Sharma MD, is an Associate Professor of Medicine in Advanced Heart Failure/Transplant Cardiology in the Division of Cardiology at the Johns Hopkins University School of Medicine. She is the Director of the Johns Hopkins Heart Failure with Preserved Ejection Fraction Program. She sees patients at The Johns Hopkins Hospital, downtown campus. A cardiologist specializing in advanced heart failure, her clinical interests include advanced heart failure diagnosis and management, heart transplantation, and mechanical circulatory support including left ventricular assist devices. She has a specialized interest in heart failure with preserved ejection fraction (HFpEF), and directs one of the largest programs in the country dedicated to caring for patients with this condition. She is the principal investigator of numerous clinical and translational trials in HFpEF and leads a team of nurses, research coordinators, and fellows-in-training in this multi-faceted program. She is an invited speaker at national meetings in topic areas covering advanced heart failure and HFpEF. Dr. Sharma is a member of the American Heart Association, the American College of Cardiology, the Heart Failure Society of America, and the International Society of Heart and Lung Transplantation. Dr. Sharma is rated as an Experienced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. Her top areas of expertise are Primary Localized Cutaneous Amyloidosis, Cardiac Amyloidosis, Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, and Cardiac Ablation.

Rani Hasan is an Interventional Cardiologist in Baltimore, Maryland. Dr. Hasan is rated as an Experienced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Aortic Valve Stenosis, Apoplexy, Heart Attack, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Aronis is an Assistant Professor of Medicine in the Division of Cardiology at the Johns Hopkins School of Medicine, the Director of the Complex Adult Congenital Heart Disease Ablation Program, and the Associate Director of the Ventricular Tachycardia Ablation Program. He performs all types of electrophysiology procedures, with a special focus on complex catheter ablations for atrial and ventricular arrhythmias as well as complex ablations for arrhythmias in patients with adult congenital heart diseases. Dr. Aronis received his M.D. and Ph.D. degrees with Summa Cum Laude honors from the University of Patras School of Medicine in Greece. He completed his internal medicine residency training at Boston University Medical Center both his Cardiovascular Disease and Clinical Cardiac Electrophysiology fellowships at The Johns Hopkins Hospital. In addition, he has completed a post-doctoral research fellowship in Translational Research at Beth Israel Deaconess Medical Center / Harvard Medical School and an NIH funded (T-32) post-doctoral research fellowship in computational electrophysiology at the Institute of Computational Medicine at the Johns Hopkins Whiting School of Engineering. He actively engages in clinical trials and research studies aimed at improving patient outcomes and advancing the understanding of cardiac arrhythmias. He is a member of the American College of Cardiology, American Heart Association, and Heart Rhythm Society. Dr. Aronis is rated as an Experienced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Atrial Fibrillation, Ventricular Tachycardia, Arrhythmias, Cardiac Ablation, and Pacemaker Implantation.

Dr. Nisha A. Gilotra is a cardiologist in the Johns Hopkins Medicine Division of Cardiology with expertise in advanced heart failure, including the care of heart transplant and ventricular assist device patients. Dr. Gilotra specializes in inflammatory cardiomyopathies, including sarcoidosis, myocarditis and inherited causes of cardiomyopathy. Dr. Gilotra received her medical degree from Jefferson Medical College in Philadelphia, PA. She completed her medical residency, general cardiology fellowship and advanced heart failure fellowship at Johns Hopkins University School of Medicine. Between fellowships, she served as an Assistant Chief of Service for the Department of Medicine. Dr. Gilotra is rated as an Experienced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. Her top areas of expertise are Sarcoidosis, Myocarditis, Cardiomyopathy, Heart Transplant, and Endoscopy.

Robert Hood is a Cardiologist in Baltimore,, Maryland. Dr. Hood is rated as an Advanced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Familial Ventricular Tachycardia, Necrosis, Mitral Valve Regurgitation, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

Stephen Gottlieb is a Cardiologist in Baltimore,, Maryland. Dr. Gottlieb is rated as an Experienced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Heart Failure, Cardiomyopathy, Apoplexy, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Bradley Maron is a Cardiologist in Baltimore,, Maryland. Dr. Maron is rated as an Experienced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Pulmonary Hypertension, Hypertension, Heart Failure, Hypertrophic Cardiomyopathy (HCM), and Heart Transplant.

Dr. Gary Gerstenblith is professor of medicine and director of clinical trials in the Johns Hopkins Medicine Division of Cardiology. He also serves as attending physician in r the Cardiology care Unit. Dr. Gerstenblith earned his undergraduate degree from New York University and his medical degree from the University of Pennsylvania School of Medicine. After working at the National Institute on Aging and the National Institutes of Health (NIH) and completing a fellowship at Jackson Memorial Hospital in Miami, Dr. Gerstenblith joined the faculty of the Johns Hopkins University School of Medicine. Dr. Gerstenblith conducts clinical trials in patients with cardiovascular disease. His research interests include the impact of cardiovascular aging on cardiac structure and function, and the use of stem cells to repair damaged cardiac muscle. He has published nearly 250 articles and book chapters and has been a referee for numerous journals including Circulation, The New England Journal of Medicine and The Journal of the American College of Cardiology. Dr. Gerstenblith is rated as an Experienced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Heart Attack, Atherosclerosis, Coronary Heart Disease, Apoplexy, and Percutaneous Coronary Intervention (PCI).